| hm | homozygous | ht | heterozygous | tg | involves transgenes | √ | phenotype observed |
| cn | conditional genotype | cx | complex: > 1 genome feature | ot | other: hemizygous, indeterminate,... | N | normal phenotype |
Background:
| Affected Systems | |||||
|---|---|---|---|---|---|
cardiovascular system
|
√ | √ | √ | √ | |
|
increased myocardial fiber size
|
√ | ||||
|
increased heart left ventricle weight
|
√ | ||||
|
decreased heart left ventricle wall thickness
|
√ | ||||
|
dilated heart left ventricle
|
√ | √ | √ | √ | |
|
cardiac fibrosis
|
√ | ||||
|
abnormal cardiovascular system physiology
|
√ | ||||
|
dilated cardiomyopathy
|
√ | ||||
|
decreased cardiac muscle contractility
|
√ | √ | √ | √ | |
|
abnormal response of heart to induced stress
|
√ | ||||
|
increased response of heart to induced stress
|
√ | ||||
|
homeostasis/metabolism
|
√ | ||||
|
abnormal response of heart to induced stress
|
√ | ||||
|
increased response of heart to induced stress
|
√ | ||||
|
mortality/aging
|
√ | √ | √ | ||
|
premature death
|
√ | √ | √ | ||
|
muscle
|
√ | √ | √ | √ | |
|
increased myocardial fiber size
|
√ | ||||
|
dilated cardiomyopathy
|
√ | ||||
|
decreased cardiac muscle contractility
|
√ | √ | √ | √ |
